Research Focus

Former Employee. Pharmacy; Clinical Pharmacy Specialist I

Recent additions – View all

1. The clinical utility of strict laboratory monitoring of CDK 4/6 inhibitors in metastatic breast cancer patients

   Meeting Abstract

   Patel, U.; Meisel, J. L.; Barbee, M. S.; Frinzi, K.; Sakach, E.; Chen, Z.
   Journal of Clinical Oncology (2019)

   Fulltext@MSK | Save
2. Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology

   Journal Article

   Barbee, M. S.; Ogunniyi, A.; Horvat, T. Z.; Dang, T. O.
   Annals of Pharmacotherapy (2015)

   Fulltext@MSK | Save
3. Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients

   Journal Article

   Barbee, M. S.; Nooka, A.; Kaufman, J. L.; Kim, S.; Chen, Z.; Heffner, L. T. Jr; Lonial, S.; Harvey, R. D.
   Cancer (2015)

   Fulltext@MSK | Save